Health Trials

Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (R/R B-NHL)

1

Review clinical trials related to Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (R/R B-NHL). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Clinical Study on the Safety and Efficacy of CD20/CD19 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Evaluate the safety and tolerability of AcNK-Sup003 cell injection in subjects with relapsed or refractory B-cell non-Hodgkin lymphoma (R/R B-NHL). To preliminarily determine the Maximum Tolerated Dose (MTD) or recommended clinical dose of AcNK-Sup003 cell injection.

Participants needed: 28
Trial details
Age: 18-78Biological sex: AllType: InterventionalSponsor: Donghua ZhangUpdated: Jan 16, 2026Locations: 1
Eligibility criteria

Not listed

Read more